Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions

被引：46
|
作者：
Schweighardt, B [1 ]
Ortiz, GM
Grant, RM
Wellons, M
Miralles, GD
Kostrikis, LG
Bartlett, JA
Nixon, DF
机构：
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[2] Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC USA
[3] Trimeris Pharmaceut, Durham, NC USA
[4] Univ Athens, Sch Med, GR-11527 Athens, Greece
来源：
AIDS | 2002年 / 16卷 / 17期
关键词：
D O I：
10.1097/00002030-200211220-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report the emergence of drug-resistant viral mutations in chronically HIV-infected individuals undergoing structured treatment interruptions (STI). The protease mutation M46L and the reverse transcriptase mutations K101E and K103N were detected at the end of the second or third STI. We conclude that the repeated abrupt termination and resumption of certain antiretroviral drug regimens during STI therapy may lead to the development of drug resistance in chronically HIV-infected individuals.
引用
收藏
页码：2342 / 2344
页数：3
相关论文
共 50 条
  • [31] Stability of transmitted drug-resistant HIV-1 species
    Cane, PA
    CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) : 537 - 542
  • [32] Inhibition of drug-resistant HIV-1 by RNA interference
    Huelsmann, PM
    Rauch, P
    Allers, K
    John, MJ
    Metzner, KJ
    ANTIVIRAL RESEARCH, 2006, 69 (01) : 1 - 8
  • [33] Drug-resistant HIV-1 - The virus strikes back
    Mayers, DL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24): : 2000 - 2002
  • [34] Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
    Vercauteren, Jurgen
    Wensing, Annemarie M. J.
    van de Vijver, David A. M. C.
    Albert, Jan
    Balotta, Claudia
    Hamouda, Osamah
    Kuecherer, Claudia
    Struck, Daniel
    Schmit, Jean-Claude
    Asjo, Birgitta
    Bruckova, Marie
    Camacho, Ricardo J.
    Clotet, Bonaventura
    Coughlan, Suzie
    Grossman, Zehava
    Horban, Andrzej
    Korn, Klaus
    Kostrikis, Leondios
    Nielsen, Claus
    Paraskevis, Dimitrios
    Poljak, Mario
    Puchhammer-Stoeckl, Elisabeth
    Riva, Chiara
    Ruiz, Lidia
    Salminen, Mika
    Schuurman, Rob
    Sonnerborg, Anders
    Stanekova, Danica
    Stanojevic, Maja
    Vandamme, Anne-Mieke
    Boucher, Charles A. B.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (10): : 1503 - 1508
  • [35] Evolutionary pathways of transmitted drug-resistant HIV-1
    Pingen, Marieke
    Nijhuis, Monique
    de Bruijn, Johan A.
    Boucher, Charles A. B.
    Wensing, Annemarie M. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) : 1467 - 1480
  • [36] Establishment of Drug-Resistant HIV-1 in Latent Reservoirs
    Dahl, Viktor
    Palmer, Sarah
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (09): : 1258 - 1260
  • [37] Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase
    Berkhout, Ben
    Back, Nicole K. T.
    de Ronde, Anthony
    Jurriaans, Suzanne
    Bakker, Margreet
    Parkin, Neil T.
    van der Hoek, Lia
    AIDS, 2006, 20 (11) : 1515 - 1520
  • [38] Transmission of Drug-Resistant HIV-1 Variants Among Individuals with Recent Infection in Southern Poland
    Smolen-Dzirba, Joanna
    Rosinska, Magdalena
    Kruszynski, Piotr
    Bratosiewicz-Wasik, Jolanta
    Janiec, Janusz
    Beniowski, Marek
    Bociaga-Jasik, Monika
    Jablonowska, Elzbieta
    Szetela, Bartosz
    Wasik, Tomasz J.
    CURRENT HIV RESEARCH, 2013, 11 (04) : 288 - 294
  • [39] When Do Minority Drug-Resistant HIV-1 Variants Have a Major Clinical Impact?
    Heneine, Walid
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 647 - 649
  • [40] Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe:: Implications for clinical management
    Wensing, AMJ
    van de Vijver, DA
    Angarano, G
    Asjo, B
    Balotta, C
    Boeri, E
    Camacho, R
    Chaix, ML
    Costagliola, D
    De Luca, A
    Derdelinckx, I
    Grossman, Z
    Hamouda, O
    Hatzakis, A
    Hemmer, R
    Hoepelman, A
    Horban, A
    Korn, K
    Kücherer, C
    Leitner, T
    Loveday, C
    MacRae, E
    Maljkovic, I
    de Mendoza, C
    Meyer, L
    Nielsen, C
    de Coul, ELO
    Ormaasen, V
    Paraskevis, D
    Perrin, L
    Puchhammer-Stockl, E
    Ruiz, L
    Salminen, M
    Schmit, JC
    Schneider, F
    Schuurman, R
    Soriano, V
    Stanczak, G
    Stanojevic, M
    Vandamme, AM
    Van Laethem, K
    Violin, M
    Wilbe, K
    Yerly, S
    Zazzi, M
    Boucher, CA
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06): : 958 - 966
12345